海南海药(000566.SZ):目前公司正进行氟非尼酮Ⅱ期临床数据分析工作
Group 1 - The company is currently conducting data analysis for the Phase II clinical trial of Fluorofenone [1] - Investors are advised to pay attention to the relevant announcements disclosed by the company regarding the clinical trial report [1]